Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.
Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.
复制标题
DOI:
10.1002/hep.26657
复制
发表时间:
2014-04
期刊:
影响因子:
13.5
通讯作者:
Kleinstein, Steven H.
中科院分区:
文献类型:
--
作者:
Bolen, Christopher R.;Ding, Siyuan;Robek, Michael D.;Kleinstein, Steven H.
Despite activating similar signaling cascades, the type I and type III interferons (IFNs) differ in their ability to antagonize virus replication. However, it is not clear whether these cytokines induce unique antiviral states, particularly in the liver, where the clinically important hepatitis B and C viruses cause persistent infection. Here, clustering and promoter analysis of microarray-based gene expression profiling was combined with mechanistic studies of signaling pathways to dynamically characterize the transcriptional responses induced by these cytokines in Huh7 hepatoma cells and primary human hepatocytes. Type I and III IFNs differed greatly in their level of interferon-stimulated gene (ISG) induction with a clearly detectable hierarchy (IFN-β > IFN-α > IFN-λ3 > IFN-λ1 > IFN-λ2). Notably, although the hierarchy identified varying numbers of differentially expressed genes when quantified using common statistical thresholds, further analysis of gene expression over multiple time points indicated that the individual IFNs do not in fact regulate unique sets of genes. The kinetic profiles of IFN-induced gene expression were also qualitatively similar with the important exception of IFN-α. While stimulation with either IFN-β or IFN-λs resulted in a similar long-lasting ISG induction, IFN-α signaling peaked early after stimulation then declined due to a negative feedback mechanism. The quantitative expression hierarchy and unique kinetics of IFN-α reveal potential specific roles for individual IFNs in the immune response, and elucidate the mechanism behind previously observed differences in IFN antiviral activity. While current clinical trials are focused on IFN-λ1 as a potential antiviral therapy, the finding that IFN-λ3 invariably possesses the highest activity among type III IFNs suggests that this cytokine may have superior clinical activity.
登录
查看更多内容
影响因子:
3.7
作者:
Pagliaccetti NE;Chu EN;Bolen CR;Kleinstein SH;Robek MD
通讯作者:
Robek MD
影响因子:
3.8
作者:
Schulze-Bergkamen H;Fleischer B;Schuchmann M;Weber A;Weinmann A;Krammer PH;Galle PR
通讯作者:
Galle PR
影响因子:
3.8
作者:
Meager, A;Visvalingam, K;Wadhwa, M
通讯作者:
Wadhwa, M
影响因子:
4.1
作者:
Francois-Newton, Veronique;Livingstone, Mark;Pellegrini, Sandra
通讯作者:
Pellegrini, Sandra
影响因子:
4.8
作者:
Schmid, Sonja;Mordstein, Markus;tenOever, Benjamin R.
通讯作者:
tenOever, Benjamin R.